Apophysomyces elegans Caused Rhino-Orbito Mucormycosis: An Emerging Infection in Immunocompetent Individuals

Mucormycosis is a rare necrotizing angioinvasive infection caused by fungi of the class Zygomycetes (order Mucorales). It predominantly occurs in immunocompromised/ predisposed individuals. Recent surge in its incidence in healthy individuals has emphasized the need to reconsider our age-old presumption of 'mucormycosis as a classical opportunistic infection'. Apophysomyces elegans has emerged as a pathogen causing invasive Rhino-Orbitocerebral Mucormycosis (ROCM), mostly in immunocompetent individuals. Mostly resistant to commonly used azoles and echinocandins, management of A elegans associated ROCM solely depends on radical debridement and Amphotericin B. Recent reports of Amphotericin B resistant A elegans strains is disturbing. Till date only 12 cases of ROCM in immunocompetent/ otherwise healthy individuals attributable to A elegans has been reported. Our main objective is to delineate the clinical characteristics and treatment outcome of immunocompentent/ otherwise healthy individuals suffering from A elegans caused ROCM. We also report four new cases of A. elagans caused ROCM. J Microbiol Infect Dis 2017; 7(4):207-212

___

  • 1. Mignogna MD, Fortuna G, Leuci S, et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 2011; 15(8): e533-40. 2. Chakrabarti A, Ghosh A, Prasad GS, et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol 2003; 41(2):783-788. 3. Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol 1977; 103:600-4. 4. Parsi K, Itgampalli RK, Vittal R, Kumar A. Perineural spread of rhino-orbitocerebral mucourmycosis caused by Apophysomyces elegans. Ann Indian Acad Neurol 2013;16(3):414-7. 5. Okhuysen PC, Rex JH, Kapusta M, Fife C. Successful treatment of extensive posttraumatic soft tissue and renal infection due to Apophysomyces elegans. Clin Infect Dis 1994;19:329-31 6. Radner AB, Witt MD, Edwards JE Jr. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect dis. 1995; 20(1):163-166. 7. Brown SR, Shah IA, Grinstead M. Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am J Rhinol. 1998; 12(4):289-292. 8. Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology. 2000; 107(3):555-558. 
9. Rao SS, Panda NK, Pragache G, Chakrabarti A, Saravanan K. Sinoorbital mucormycosis due to Apophysomyces elegans in immunocompetent individuals-an increasing trend. Am J Otolaryngol. 2006; 27(5): 366-369 10. Schütz P, Behbehani JH, Khan ZU, et al. Fatal rhino-orbito-cerebral zygomycosis caused by Apophysomyces elegans in a healthy patient. J Oral Maxillofac Surg. 2006;64(12):1795-802. 11. Garcia-Covarrubias L, Bartlett R, Barratt DM, Wassermann RJ. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. J Trauma 2001; 50(2):353-7. 12. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10 Suppl 1:31-47. 13. Chakrabarti A, Panda N, Varma SC, et al. Craniofacial Zygomycosis caused by Apophysomyces elegans. Mycoses 1997;40(11-12): 419 - 21. 14. Biswas D, Kotwal A, Kakati B, Ahmad S. Amphotericin B Resistant Apophysomyces elegans Causing Rhino-oculo-Cerebral Mucormycosis in an immunocompetent host. J Clin Diagn Res 2015; 9(8):DD01-2. 15. Liang KP, Tleyjeh IM, Wilson WR, Robert GD, Temesgen Z. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol. 2006; 44(3):892-8. 16. Kimura M, Smith MB, McGinnis MR. Zygomycosis due to Apophysomyces elegans: report of 2 cases and review of the literature. Arch Pathol Lab Med 1999;123(5):386–90. 
 17. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, Mucor and Lichtheimia species. Clin Microbiol Rev 2011; 24(2):411-445. 18. Chakrabarti A, Shivaprakash MR, Curfs-Breuker I, Baghela A, Klaassen CH, Meis JF.Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern. J. Clin. Microbiol 2010; 48:4580-4585.